Defined protein-drug conjugates for pharma
| Date | Round | Amount |
|---|---|---|
| Nov 2023 | Seed Austrian biotech Valanx raised EUR 2.3M (equity and public funding) from SkyGene, xista science ventures, tecnet equity and SOSV. | $2.5M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.